A prostate cancer diagnosis can be devastating news for the one in seven men who develop the disease in their lifetimes. Annually, 30,000...

We recently sat down with our founder to ask 10 questions about the company, the industry, and what are the options men have when facing...

We recently sat down with our CEO in his library to discuss the mission, vision, and values of Bot Image. We discussed ProstatID and the...

In our "Meet the Team" series, our knowledgeable teammates discuss the major trends, impact, and technology of artificial intelligence in...

In our "Meet the Team" series, our knowledgeable teammates discuss the major trends, impact, and technology of artificial intelligence in...

We're proud to announce that in partnership with our beta testing site, we processed our first test case using the cloud-based...

The Bot Image team has been hard at work trying to obtain FDA clearance. We're excited to announce that we have passed the first major...

Trial Site News features the latest coverage of clinical research. Read the article here: https://www.trialsitenews.com/bot-image-inc-exp...

Dr. Ethan Ulrich, our lead software engineer has published a detailed piece about the technology behind ProstatID. You can read his...

Silicone Prairie News, the leading start-up news source of the Midwest has featured Bot Image in a new article. You can read their...

In partnership with Start Engine, Bot Image is now offering Class B shares to the public. Minimum investment begins at $504 for 34...